Author = Nahayati, Mohammad Ali
Alopecia universalis in a patient under treatment of Ocrelizumab after switching from Rituximab (PP-06)

Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), December 2023

Mahshid Mahyad; Mohammad Ali Nahayati; Maryam Ebrahimian


Demyelinating etiology as a possible cause of Parry–Romberg Syndrome (PP-14)

Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), December 2023

K. Bahrami; Mohammad Ali Nahayati; Mohammad Shriati


Diagnosis of multiple sclerosis and Fahr's Disease in a young woman: A case report (PP-15)

Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), December 2023

Mohammadreza Malek Zadeh; Pourandokht Mousavian; Mohammad Ali Nahayati